Healthcare Contract Manufacturing Market Likely to Surpass USD 611 Billion by 2035

Global Healthcare Contract Manufacturing Market Forecast 2035:

According to the report, the global healthcare contract manufacturing market is likely to grow from USD 193.2 Billion in 2025 to USD 610.9 Billion in 2035 at a highest CAGR of 12.2% during the time period. The global healthcare contract manufacturing market is propelled by the acceleration of biologics pipelines, reshoring strategies, and scaling demands for fill-finish capabilities. In early 2025, Samsung Biologics signed a record deal with a large Asian drug company worth $1.2 billion to aid production of biologics, highlighting the dependence of the world on CDMOs to provide capacity and speed.

Novo Holdings also finalized its $ 16.5 billion acquisition of Catalent manufacturing operations in late 2024 to gain manufacturing control over the important weight-loss drugs Ozempic and Wegovy. A data published by industry associations also signal this trend: the investment in CMOs by private equity is steadily rising as companies are finding more and more reliable and scalable manufacturing platforms after the pandemic. These manufacture-level strategies of biologic complexity and capacity urgency are transforming the landscape of healthcare manufacturing to an outsourcing-dominant approach.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Healthcare Contract Manufacturing Market

Advancing complexity of cell and gene therapies is compelling pharmaceutical firms to become more reliant on specialized contract manufacturers that have the expertise in the advanced biologics. The recent upsurge in the demand of viral vectors resulted in the expansion of Lonza viral vectors production facilities in the U.S. as an example of the high technical outsourcing relationships becoming essential.

High regulatory examination in various regions frequently postpones the production schedules and poses additional compliance expenses to CDMOs. An example is the FDA inspections of sterile production plants in foreign countries in 2024 that led to bottlenecks in production of some injectable drugs, which restricted efficiency and delivery promises by manufacturers.

Increasing the uses of digital manufacturing technologies and artificial intelligence-based quality control solutions is a significant chance of CDMOs to differentiate services. WuXi STA is the new smart manufacturing platform that is based on predictive maintenance AI-based and allows faster turnaround times and enhanced reliability to its clients who are aiming to find more efficient outsourcing partners.

“Impact of Tariff Rates on Healthcare Contract Manufacturing”

Introduction and change of tariff rates has a significant impact on the global healthcare contract manufacturing market, especially with regard to cross border pharmaceutical and medical device supply chain. High customs on raw materials like active pharmaceutical ingredients (APIs), bioprocessing consumables, or specialized medical device components may cause operations costs to rise among contract manufacturers, which will cause a price burden along the value chain.
The U.S. tariff changes on imported Chinese APIs in 2025 led several contract manufacturing organizations (CMOs) such as Lonza and WuXi AppTec to review their sourcing strategies, with some relocating production to regions to reduce risk. Although tariffs initially drive up prices, they are also triggering an acceleration in the creation of localized production centers, particularly in North America and Europe, thus transforming the game of global outsourcing.

Regional Analysis of Global Healthcare Contract Manufacturing Market

The Asia Pacific region has the highest demand globally of healthcare contract manufacturing mainly because of production, which is cost effective, increasing biologics capacities and good government support to local pharmaceutical facilities. The example of how big players take advantage of the competitive environment in Asia Pacific is the announcement of a multibillion-dollar expansion of its Incheon facilities to enhance its biologics capacity by Samsung Biologics in 2025. It is this rampant capacity and experience that is still drawing multinational pharmaceutical companies to outsource manufacturing to the region. The prevailing power of Asia Pacific makes sure that the region will continue to be the backbone of global outsourcing, enhancing the position of the region as the centre of scalable, cost-effective manufacturing.
In the North American region, the market of healthcare contract manufacturing is growing strongly as there is an upsurge in the demand of complex biologics and advanced therapies. The case of Catalent and Moderna in 2025 to produce mRNA vaccines on a large scale in the U.S. shows that the region has led in the production of advanced therapies.
The rise of Europe is attributable to increasing focus on sustainable pharmaceutical production and resilience of local supply chain. The long-term competitiveness in healthcare contract manufacturing is demonstrated by the fact that Recipharm invested in 2025 in the eco-friendly sterile manufacturing plants in France, where green chemistry and energy-efficient processes are of strategic interest.

Prominent players operating in the global healthcare contract manufacturing market are Alcami Corporation, Baxter BioPharma Solutions, Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Celestica Inc., Delpharm Group, Evonik Industries AG, Famar SA, Fareva Group, FLEX LTD., FUJIFILM Diosynth Biotechnologies, Hovione FarmaCiencia SA, ICROM S.p.A., Integer Holdings Corporation, Jabil Inc., Jubilant Pharmova Ltd., Lonza, Nordson Corporation, Phillips-Medisize, Piramal Pharma Solutions, Plexus Corp., Recipharm AB, Samsung Biologics, Sanmina Corporation, Siegfried Holding AG, Synecco Ltd, Thermo Fisher Scientific Inc., Viant Technology LLC, West Pharmaceutical Services, Inc., Wuxi AppTec, and Other Key Players.

The global healthcare contract manufacturing market has been segmented as follows:

Global Healthcare Contract Manufacturing Market Analysis, by Service Type

API Manufacturing
Finished Dosage Formulation
Packaging & Labeling
Device Fabrication
Clinical Supply Manufacturing
Process Development & Scale-Up
Regulatory Compliance & Filing Assistance
Others

Global Healthcare Contract Manufacturing Market Analysis, by Product Type

Pharmaceutical Products
- Oral Solid Dosage Forms
- Injectable Drugs
- Topical & Transdermal Products
- Inhalable Products
- Others
Biologics
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapies
- Recombinant Proteins
- Others
Medical Devices
- Surgical Instruments
- Catheters & Tubes
- Diagnostic Equipment
- Implantable Devices
- Others
Diagnostics & Consumables
- Test Kits
- Lab Reagents
- Microfluidic Cartridges
- Others
Nutraceuticals
- Herbal Extracts
- Functional Foods
- Probiotic Capsules
- Others

Global Healthcare Contract Manufacturing Market Analysis, by Contract Type

Full-Service Contract Manufacturing
Fee-for-Service (Per Batch or Unit)
Dedicated Manufacturing Partnerships
Build-to-Suit/Onsite Facilities for Clients)
Others

Global Healthcare Contract Manufacturing Market Analysis, by Manufacturing Scale

Preclinical/Pilot-Scale Manufacturing
Clinical Trial Manufacturing (Phase I–III)
Commercial-Scale Manufacturing
High-Volume Commodity Production

Global Healthcare Contract Manufacturing Market Analysis, by Device Class (For Medical Devices)

Class I (Low Risk)
Class II (Moderate Risk)
Class III (High Risk, Life-Sustaining Devices)

Global Healthcare Contract Manufacturing Market Analysis, by End-user

Large Multinational Healthcare Corporations
Mid-Sized Specialty Healthcare Firms
Emerging Biotech Startups
Academic/Non-Profit Spin-Offs
Generic Drug Manufacturers
Others

Global Healthcare Contract Manufacturing Market Analysis, by Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global Healthcare Contract Manufacturing Market Outlook
  - 2.1.1. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2025-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Chemicals & Materials Industry Overview, 2025
  - 3.1.1. Industry Ecosystem Analysis
  - 3.1.2. Key Trends for Chemicals & Materials Industry
  - 3.1.3. Regional Distribution for Chemicals & Materials Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.4. Trade Analysis
  - 3.4.1. Import & Export Analysis, 2025
  - 3.4.2. Top Importing Countries
  - 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
  - 3.5.1. Manufacturer
    - 3.5.1.1. Based on the component & Raw material
  - 3.5.2. Supply Chain
  - 3.5.3. End Consumer
- 3.6. Raw Material Analysis
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rising demand for biologics, personalized medicines, and complex therapeutics requiring specialized manufacturing
    - 4.1.1.2. Cost-efficiency and scalability benefits from outsourcing production, allowing pharmaceutical companies to focus on R&D
  - 4.1.2. Restraints
    - 4.1.2.1. Stringent regulatory compliance and quality standards across multiple regions, leading to operational complexity.
    - 4.1.2.2. High dependence on specialized raw materials and advanced technology suppliers, increasing production costs and supply chain risk
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
  - 4.4.1. Raw Material & Component Suppliers
  - 4.4.2. Healthcare Contract Manufacturers
  - 4.4.3. Distributors/ Suppliers
  - 4.4.4. End-users/ Customers
- 4.5. Cost Structure Analysis
  - 4.5.1. Parameter’s Share for Cost Associated
  - 4.5.2. COGP vs COGS
  - 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
  - 4.6.1. Regional Pricing Analysis
  - 4.6.2. Segmental Pricing Trends
  - 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. Global Healthcare Contract Manufacturing Market Demand
  - 4.9.1. Historical Market Size - in Value (US$ Bn), 2020-2024
  - 4.9.2. Current and Future Market Size - in Value (US$ Bn), 2025–2035
    - 4.9.2.1. Y-o-Y Growth Trends
    - 4.9.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global Healthcare Contract Manufacturing Market Analysis, by Service Type
- 6.1. Key Segment Analysis
- 6.2. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, by Service Type, 2021-2035
  - 6.2.1. API Manufacturing
  - 6.2.2. Finished Dosage Formulation
  - 6.2.3. Packaging & Labeling
  - 6.2.4. Device Fabrication
  - 6.2.5. Clinical Supply Manufacturing
  - 6.2.6. Process Development & Scale-Up
  - 6.2.7. Regulatory Compliance & Filing Assistance
  - 6.2.8. Others
7. Global Healthcare Contract Manufacturing Market Analysis, by Product Type
- 7.1. Key Segment Analysis
- 7.2. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
  - 7.2.1. Pharmaceutical Products
    - 7.2.1.1. Oral Solid Dosage Forms
    - 7.2.1.2. Injectable Drugs
    - 7.2.1.3. Topical & Transdermal Products
    - 7.2.1.4. Inhalable Products
    - 7.2.1.5. Others
  - 7.2.2. Biologics
    - 7.2.2.1. Monoclonal Antibodies
    - 7.2.2.2. Vaccines
    - 7.2.2.3. Cell & Gene Therapies
    - 7.2.2.4. Recombinant Proteins
    - 7.2.2.5. Others
  - 7.2.3. Medical Devices
    - 7.2.3.1. Surgical Instruments
    - 7.2.3.2. Catheters & Tubes
    - 7.2.3.3. Diagnostic Equipment
    - 7.2.3.4. Implantable Devices
    - 7.2.3.5. Others
  - 7.2.4. Diagnostics & Consumables
    - 7.2.4.1. Test Kits
    - 7.2.4.2. Lab Reagents
    - 7.2.4.3. Microfluidic Cartridges
    - 7.2.4.4. Others
  - 7.2.5. Nutraceuticals
    - 7.2.5.1. Herbal Extracts
    - 7.2.5.2. Functional Foods
    - 7.2.5.3. Probiotic Capsules
    - 7.2.5.4. Others
8. Global Healthcare Contract Manufacturing Market Analysis, by Contract Type
- 8.1. Key Segment Analysis
- 8.2. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, by Contract Type, 2021-2035
  - 8.2.1. Full-Service Contract Manufacturing
  - 8.2.2. Fee-for-Service (Per Batch or Unit)
  - 8.2.3. Dedicated Manufacturing Partnerships
  - 8.2.4. Build-to-Suit/Onsite Facilities for Clients)
  - 8.2.5. Others
9. Global Healthcare Contract Manufacturing Market Analysis, by Manufacturing Scale
- 9.1. Key Segment Analysis
- 9.2. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, by Manufacturing Scale, 2021-2035
  - 9.2.1. Preclinical/Pilot-Scale Manufacturing
  - 9.2.2. Clinical Trial Manufacturing (Phase I–III)
  - 9.2.3. Commercial-Scale Manufacturing
  - 9.2.4. High-Volume Commodity Production
10. Global Healthcare Contract Manufacturing Market Analysis, by Device Class (For Medical Devices)
- 10.1. Key Segment Analysis
- 10.2. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, by Device Class (For Medical Devices), 2021-2035
  - 10.2.1. Class I (Low Risk)
  - 10.2.2. Class II (Moderate Risk)
  - 10.2.3. Class III (High Risk, Life-Sustaining Devices)
11. Global Healthcare Contract Manufacturing Market Analysis, by End-user
- 11.1. Key Segment Analysis
- 11.2. Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-user, 2021-2035
  - 11.2.1. Large Multinational Healthcare Corporations
  - 11.2.2. Mid-Sized Specialty Healthcare Firms
  - 11.2.3. Emerging Biotech Startups
  - 11.2.4. Academic/Non-Profit Spin-Offs
  - 11.2.5. Generic Drug Manufacturers
  - 11.2.6. Others
12. Global Healthcare Contract Manufacturing Market Analysis and Forecasts, by Region
- 12.1. Key Findings
- 12.2. Healthcare Contract Manufacturing Market Size (Volume - Million Units and Value - US$ Mn), Analysis, and Forecasts, by Region, 2021-2035
  - 12.2.1. North America
  - 12.2.2. Europe
  - 12.2.3. Asia Pacific
  - 12.2.4. Middle East
  - 12.2.5. Africa
  - 12.2.6. South America
13. North America Healthcare Contract Manufacturing Market Analysis
- 13.1. Key Segment Analysis
- 13.2. Regional Snapshot
- 13.3. North America Healthcare Contract Manufacturing Market Size Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 13.3.1. Service Type
  - 13.3.2. Product Type
  - 13.3.3. Contract Type
  - 13.3.4. Manufacturing Scale
  - 13.3.5. Device Class (For Medical Devices)
  - 13.3.6. End-user
  - 13.3.7. Country
    - 13.3.7.1. USA
    - 13.3.7.2. Canada
    - 13.3.7.3. Mexico
- 13.4. USA Healthcare Contract Manufacturing Market
  - 13.4.1. Country Segmental Analysis
  - 13.4.2. Service Type
  - 13.4.3. Product Type
  - 13.4.4. Contract Type
  - 13.4.5. Manufacturing Scale
  - 13.4.6. Device Class (For Medical Devices)
  - 13.4.7. End-user
- 13.5. Canada Healthcare Contract Manufacturing Market
  - 13.5.1. Country Segmental Analysis
  - 13.5.2. Service Type
  - 13.5.3. Product Type
  - 13.5.4. Contract Type
  - 13.5.5. Manufacturing Scale
  - 13.5.6. Device Class (For Medical Devices)
  - 13.5.7. End-user
- 13.6. Mexico Healthcare Contract Manufacturing Market
  - 13.6.1. Country Segmental Analysis
  - 13.6.2. Service Type
  - 13.6.3. Product Type
  - 13.6.4. Contract Type
  - 13.6.5. Manufacturing Scale
  - 13.6.6. Device Class (For Medical Devices)
  - 13.6.7. End-user
14. Europe Healthcare Contract Manufacturing Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. Europe Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 14.3.1. Service Type
  - 14.3.2. Product Type
  - 14.3.3. Contract Type
  - 14.3.4. Manufacturing Scale
  - 14.3.5. Device Class (For Medical Devices)
  - 14.3.6. End-user
  - 14.3.7. Country
    - 14.3.7.1. Germany
    - 14.3.7.2. United Kingdom
    - 14.3.7.3. France
    - 14.3.7.4. Italy
    - 14.3.7.5. Spain
    - 14.3.7.6. Netherlands
    - 14.3.7.7. Nordic Countries
    - 14.3.7.8. Poland
    - 14.3.7.9. Russia & CIS
    - 14.3.7.10. Rest of Europe
- 14.4. Germany Healthcare Contract Manufacturing Market
  - 14.4.1. Country Segmental Analysis
  - 14.4.2. Service Type
  - 14.4.3. Product Type
  - 14.4.4. Contract Type
  - 14.4.5. Manufacturing Scale
  - 14.4.6. Device Class (For Medical Devices)
  - 14.4.7. End-user
- 14.5. United Kingdom Healthcare Contract Manufacturing Market
  - 14.5.1. Country Segmental Analysis
  - 14.5.2. Service Type
  - 14.5.3. Product Type
  - 14.5.4. Contract Type
  - 14.5.5. Manufacturing Scale
  - 14.5.6. Device Class (For Medical Devices)
  - 14.5.7. End-user
- 14.6. France Healthcare Contract Manufacturing Market
  - 14.6.1. Country Segmental Analysis
  - 14.6.2. Service Type
  - 14.6.3. Product Type
  - 14.6.4. Contract Type
  - 14.6.5. Manufacturing Scale
  - 14.6.6. Device Class (For Medical Devices)
  - 14.6.7. End-user
- 14.7. Italy Healthcare Contract Manufacturing Market
  - 14.7.1. Country Segmental Analysis
  - 14.7.2. Service Type
  - 14.7.3. Product Type
  - 14.7.4. Contract Type
  - 14.7.5. Manufacturing Scale
  - 14.7.6. Device Class (For Medical Devices)
  - 14.7.7. End-user
- 14.8. Spain Healthcare Contract Manufacturing Market
  - 14.8.1. Country Segmental Analysis
  - 14.8.2. Service Type
  - 14.8.3. Product Type
  - 14.8.4. Contract Type
  - 14.8.5. Manufacturing Scale
  - 14.8.6. Device Class (For Medical Devices)
  - 14.8.7. End-user
- 14.9. Netherlands Healthcare Contract Manufacturing Market
  - 14.9.1. Country Segmental Analysis
  - 14.9.2. Service Type
  - 14.9.3. Product Type
  - 14.9.4. Contract Type
  - 14.9.5. Manufacturing Scale
  - 14.9.6. Device Class (For Medical Devices)
  - 14.9.7. End-user
- 14.10. Nordic Countries Healthcare Contract Manufacturing Market
  - 14.10.1. Country Segmental Analysis
  - 14.10.2. Service Type
  - 14.10.3. Product Type
  - 14.10.4. Contract Type
  - 14.10.5. Manufacturing Scale
  - 14.10.6. Device Class (For Medical Devices)
  - 14.10.7. End-user
- 14.11. Poland Healthcare Contract Manufacturing Market
  - 14.11.1. Country Segmental Analysis
  - 14.11.2. Service Type
  - 14.11.3. Product Type
  - 14.11.4. Contract Type
  - 14.11.5. Manufacturing Scale
  - 14.11.6. Device Class (For Medical Devices)
  - 14.11.7. End-user
- 14.12. Russia & CIS Healthcare Contract Manufacturing Market
  - 14.12.1. Country Segmental Analysis
  - 14.12.2. Service Type
  - 14.12.3. Product Type
  - 14.12.4. Contract Type
  - 14.12.5. Manufacturing Scale
  - 14.12.6. Device Class (For Medical Devices)
  - 14.12.7. End-user
- 14.13. Rest of Europe Healthcare Contract Manufacturing Market
  - 14.13.1. Country Segmental Analysis
  - 14.13.2. Service Type
  - 14.13.3. Product Type
  - 14.13.4. Contract Type
  - 14.13.5. Manufacturing Scale
  - 14.13.6. Device Class (For Medical Devices)
  - 14.13.7. End-user
15. Asia Pacific Healthcare Contract Manufacturing Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. East Asia Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Service Type
  - 15.3.2. Product Type
  - 15.3.3. Contract Type
  - 15.3.4. Manufacturing Scale
  - 15.3.5. Device Class (For Medical Devices)
  - 15.3.6. End-user
  - 15.3.7. Country
    - 15.3.7.1. China
    - 15.3.7.2. India
    - 15.3.7.3. Japan
    - 15.3.7.4. South Korea
    - 15.3.7.5. Australia and New Zealand
    - 15.3.7.6. Indonesia
    - 15.3.7.7. Malaysia
    - 15.3.7.8. Thailand
    - 15.3.7.9. Vietnam
    - 15.3.7.10. Rest of Asia Pacific
- 15.4. China Healthcare Contract Manufacturing Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Service Type
  - 15.4.3. Product Type
  - 15.4.4. Contract Type
  - 15.4.5. Manufacturing Scale
  - 15.4.6. Device Class (For Medical Devices)
  - 15.4.7. End-user
- 15.5. India Healthcare Contract Manufacturing Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Service Type
  - 15.5.3. Product Type
  - 15.5.4. Contract Type
  - 15.5.5. Manufacturing Scale
  - 15.5.6. Device Class (For Medical Devices)
  - 15.5.7. End-user
- 15.6. Japan Healthcare Contract Manufacturing Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Service Type
  - 15.6.3. Product Type
  - 15.6.4. Contract Type
  - 15.6.5. Manufacturing Scale
  - 15.6.6. Device Class (For Medical Devices)
  - 15.6.7. End-user
- 15.7. South Korea Healthcare Contract Manufacturing Market
  - 15.7.1. Country Segmental Analysis
  - 15.7.2. Service Type
  - 15.7.3. Product Type
  - 15.7.4. Contract Type
  - 15.7.5. Manufacturing Scale
  - 15.7.6. Device Class (For Medical Devices)
  - 15.7.7. End-user
- 15.8. Australia and New Zealand Healthcare Contract Manufacturing Market
  - 15.8.1. Country Segmental Analysis
  - 15.8.2. Service Type
  - 15.8.3. Product Type
  - 15.8.4. Contract Type
  - 15.8.5. Manufacturing Scale
  - 15.8.6. Device Class (For Medical Devices)
  - 15.8.7. End-user
- 15.9. Indonesia Healthcare Contract Manufacturing Market
  - 15.9.1. Country Segmental Analysis
  - 15.9.2. Service Type
  - 15.9.3. Product Type
  - 15.9.4. Contract Type
  - 15.9.5. Manufacturing Scale
  - 15.9.6. Device Class (For Medical Devices)
  - 15.9.7. End-user
- 15.10. Malaysia Healthcare Contract Manufacturing Market
  - 15.10.1. Country Segmental Analysis
  - 15.10.2. Service Type
  - 15.10.3. Product Type
  - 15.10.4. Contract Type
  - 15.10.5. Manufacturing Scale
  - 15.10.6. Device Class (For Medical Devices)
  - 15.10.7. End-user
- 15.11. Thailand Healthcare Contract Manufacturing Market
  - 15.11.1. Country Segmental Analysis
  - 15.11.2. Service Type
  - 15.11.3. Product Type
  - 15.11.4. Contract Type
  - 15.11.5. Manufacturing Scale
  - 15.11.6. Device Class (For Medical Devices)
  - 15.11.7. End-user
- 15.12. Vietnam Healthcare Contract Manufacturing Market
  - 15.12.1. Country Segmental Analysis
  - 15.12.2. Service Type
  - 15.12.3. Product Type
  - 15.12.4. Contract Type
  - 15.12.5. Manufacturing Scale
  - 15.12.6. Device Class (For Medical Devices)
  - 15.12.7. End-user
- 15.13. Rest of Asia Pacific Healthcare Contract Manufacturing Market
  - 15.13.1. Country Segmental Analysis
  - 15.13.2. Service Type
  - 15.13.3. Product Type
  - 15.13.4. Contract Type
  - 15.13.5. Manufacturing Scale
  - 15.13.6. Device Class (For Medical Devices)
  - 15.13.7. End-user
16. Middle East Healthcare Contract Manufacturing Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Middle East Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Service Type
  - 16.3.2. Product Type
  - 16.3.3. Contract Type
  - 16.3.4. Manufacturing Scale
  - 16.3.5. Device Class (For Medical Devices)
  - 16.3.6. End-user
  - 16.3.7. Country
    - 16.3.7.1. Turkey
    - 16.3.7.2. UAE
    - 16.3.7.3. Saudi Arabia
    - 16.3.7.4. Israel
    - 16.3.7.5. Rest of Middle East
- 16.4. Turkey Healthcare Contract Manufacturing Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Service Type
  - 16.4.3. Product Type
  - 16.4.4. Contract Type
  - 16.4.5. Manufacturing Scale
  - 16.4.6. Device Class (For Medical Devices)
  - 16.4.7. End-user
- 16.5. UAE Healthcare Contract Manufacturing Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Service Type
  - 16.5.3. Product Type
  - 16.5.4. Contract Type
  - 16.5.5. Manufacturing Scale
  - 16.5.6. Device Class (For Medical Devices)
  - 16.5.7. End-user
- 16.6. Saudi Arabia Healthcare Contract Manufacturing Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Service Type
  - 16.6.3. Product Type
  - 16.6.4. Contract Type
  - 16.6.5. Manufacturing Scale
  - 16.6.6. Device Class (For Medical Devices)
  - 16.6.7. End-user
- 16.7. Israel Healthcare Contract Manufacturing Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Service Type
  - 16.7.3. Product Type
  - 16.7.4. Contract Type
  - 16.7.5. Manufacturing Scale
  - 16.7.6. Device Class (For Medical Devices)
  - 16.7.7. End-user
- 16.8. Rest of Middle East Healthcare Contract Manufacturing Market
  - 16.8.1. Country Segmental Analysis
  - 16.8.2. Service Type
  - 16.8.3. Product Type
  - 16.8.4. Contract Type
  - 16.8.5. Manufacturing Scale
  - 16.8.6. Device Class (For Medical Devices)
  - 16.8.7. End-user
17. Africa Healthcare Contract Manufacturing Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Africa Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Service Type
  - 17.3.2. Product Type
  - 17.3.3. Contract Type
  - 17.3.4. Manufacturing Scale
  - 17.3.5. Device Class (For Medical Devices)
  - 17.3.6. End-user
  - 17.3.7. Country
    - 17.3.7.1. South Africa
    - 17.3.7.2. Egypt
    - 17.3.7.3. Nigeria
    - 17.3.7.4. Algeria
    - 17.3.7.5. Rest of Africa
- 17.4. South Africa Healthcare Contract Manufacturing Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Service Type
  - 17.4.3. Product Type
  - 17.4.4. Contract Type
  - 17.4.5. Manufacturing Scale
  - 17.4.6. Device Class (For Medical Devices)
  - 17.4.7. End-user
- 17.5. Egypt Healthcare Contract Manufacturing Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Service Type
  - 17.5.3. Product Type
  - 17.5.4. Contract Type
  - 17.5.5. Manufacturing Scale
  - 17.5.6. Device Class (For Medical Devices)
  - 17.5.7. End-user
- 17.6. Nigeria Healthcare Contract Manufacturing Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Service Type
  - 17.6.3. Product Type
  - 17.6.4. Contract Type
  - 17.6.5. Manufacturing Scale
  - 17.6.6. Device Class (For Medical Devices)
  - 17.6.7. End-user
- 17.7. Algeria Healthcare Contract Manufacturing Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Service Type
  - 17.7.3. Product Type
  - 17.7.4. Contract Type
  - 17.7.5. Manufacturing Scale
  - 17.7.6. Device Class (For Medical Devices)
  - 17.7.7. End-user
- 17.8. Rest of Africa Healthcare Contract Manufacturing Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Service Type
  - 17.8.3. Product Type
  - 17.8.4. Contract Type
  - 17.8.5. Manufacturing Scale
  - 17.8.6. Device Class (For Medical Devices)
  - 17.8.7. End-user
18. South America Healthcare Contract Manufacturing Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Central and South Africa Healthcare Contract Manufacturing Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Service Type
  - 18.3.2. Product Type
  - 18.3.3. Contract Type
  - 18.3.4. Manufacturing Scale
  - 18.3.5. Device Class (For Medical Devices)
  - 18.3.6. End-user
  - 18.3.7. Country
    - 18.3.7.1. Brazil
    - 18.3.7.2. Argentina
    - 18.3.7.3. Rest of South America
- 18.4. Brazil Healthcare Contract Manufacturing Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Service Type
  - 18.4.3. Product Type
  - 18.4.4. Contract Type
  - 18.4.5. Manufacturing Scale
  - 18.4.6. Device Class (For Medical Devices)
  - 18.4.7. End-user
- 18.5. Argentina Healthcare Contract Manufacturing Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Service Type
  - 18.5.3. Product Type
  - 18.5.4. Contract Type
  - 18.5.5. Manufacturing Scale
  - 18.5.6. Device Class (For Medical Devices)
  - 18.5.7. End-user
- 18.6. Rest of South America Healthcare Contract Manufacturing Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Service Type
  - 18.6.3. Product Type
  - 18.6.4. Contract Type
  - 18.6.5. Manufacturing Scale
  - 18.6.6. Device Class (For Medical Devices)
  - 18.6.7. End-user
19. Key Players/ Company Profile
- 19.1. Alcami Corporation
  - 19.1.1. Company Details/ Overview
  - 19.1.2. Company Financials
  - 19.1.3. Key Customers and Competitors
  - 19.1.4. Business/ Industry Portfolio
  - 19.1.5. Product Portfolio/ Specification Details
  - 19.1.6. Pricing Data
  - 19.1.7. Strategic Overview
  - 19.1.8. Recent Developments
- 19.2. Baxter BioPharma Solutions
- 19.3. Boehringer Ingelheim International GmbH
- 19.4. Cambrex Corporation
- 19.5. Catalent, Inc.
- 19.6. Celestica Inc.
- 19.7. Delpharm Group
- 19.8. Evonik Industries AG
- 19.9. Famar SA
- 19.10. Fareva Group
- 19.11. FLEX LTD.
- 19.12. FUJIFILM Diosynth Biotechnologies
- 19.13. Hovione FarmaCiencia SA
- 19.14. ICROM S.p.A.
- 19.15. Integer Holdings Corporation
- 19.16. Jabil Inc.
- 19.17. Jubilant Pharmova Ltd.
- 19.18. Lonza
- 19.19. Nordson Corporation
- 19.20. Phillips-Medisize
- 19.21. Piramal Pharma Solutions
- 19.22. Plexus Corp.
- 19.23. Recipharm AB
- 19.24. Samsung Biologics
- 19.25. Sanmina Corporation
- 19.26. Siegfried Holding AG
- 19.27. Synecco Ltd
- 19.28. Thermo Fisher Scientific Inc.
- 19.29. Viant Technology LLC
- 19.30. West Pharmaceutical Services, Inc.
- 19.31. Wuxi AppTec
- 19.32. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150.00

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950.00

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750.00

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation